Tirzepatide is a synthetic dual-receptor agonist targeting both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. As the second-generation incretin compound preceding retatrutide’s triple-agonist design, tirzepatide is widely studied in metabolic, glucose homeostasis, and energy balance research models. Each vial is supplied as a lyophilized powder, third-party tested for purity and identity.
GLOW / 70mg (BPC-157 + TB-500 + GHK-Cu)
$159.99You save
Peptides 101: A Research Reference Guide
$12.99You save
Tirzepatide / 10mg
$149.99
You save
- Buy 3-5 vialsSave 5%
- Buy 6-9 vialsSave 10%
- Buy 10-14 vialsSave 15%
- Buy 15+ vialsSave 25%
Discount applies automatically at checkout
Shipping & Handling
Terms Of Sale: All products are sold strictly for laboratory and research purposes. Not for human consumption, in vivo studies in humans, food use, or therapeutic application. By purchasing, you confirm you are a qualified researcher and accept full responsibility for proper handling and use.


*For laboratory and research use only. Not for human consumption.
Reviews
There are no reviews yet.